Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The main effect of Osteoarthritis Pain Drugs is to relieve pain and osteoarthritis symptoms.
The Osteoarthritis Pain Drugs market is projected to reach USD 11.7 billion by 2026 from USD 6.3 billion in 2018, at a CAGR of 9%.
The growth of the market has been driven by the rapid growth of the elderly and obese population, as well as the increase in the prevalence of osteoarthritis.
The report details the trend, potential and market size of Osteoarthritis Pain Drugs market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Osteoarthritis Pain Drugsmarket, defines the market attractiveness level of Osteoarthritis Pain Drugs market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Osteoarthritis Pain Drugs industry, describes the types of Osteoarthritis Pain Drugs market, the applications of major players and the market size, and deeply analyzes the current situation of the global Osteoarthritis Pain Drugs market and the development prospects and opportunities of Osteoarthritis Pain Drugs industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Osteoarthritis Pain Drugs market in Chapter 13.
By Player:
Johnson & Johnson
Iroko Pharmaceuticals
Sanofi
Pfizer
Mylan
GlaxoSmithKline
Almatica Pharma
Lilly
Bayer
TEVA
Abbott Laboratories
By Type:
Oral
Injection
External
By End-User:
Medical Care
Personal Care
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Osteoarthritis Pain Drugs Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Osteoarthritis Pain Drugs Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Osteoarthritis Pain Drugs Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Osteoarthritis Pain Drugs Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Osteoarthritis Pain Drugs Market Analysis and Outlook to 2022
-
7.1 Global Osteoarthritis Pain Drugs Consumption (2017-2022)
-
7.2 United States Osteoarthritis Pain Drugs Consumption (2017-2022)
-
7.3 Europe Osteoarthritis Pain Drugs Consumption (2017-2022)
-
7.4 China Osteoarthritis Pain Drugs Consumption (2017-2022)
-
7.5 Japan Osteoarthritis Pain Drugs Consumption (2017-2022)
-
7.6 India Osteoarthritis Pain Drugs Consumption (2017-2022)
-
7.7 South Korea Osteoarthritis Pain Drugs Consumption (2017-2022)
8 Region and Country-wise Osteoarthritis Pain Drugs Market Analysis and Outlook to 2028
-
8.1 Global Osteoarthritis Pain Drugs Consumption Forecast (2022-2028)
-
8.2 United States Osteoarthritis Pain Drugs Consumption Forecast (2022-2028)
-
8.3 Europe Osteoarthritis Pain Drugs Consumption Forecast (2022-2028)
-
8.4 China Osteoarthritis Pain Drugs Consumption Forecast (2022-2028)
-
8.5 Japan Osteoarthritis Pain Drugs Consumption Forecast (2022-2028)
-
8.6 India Osteoarthritis Pain Drugs Consumption Forecast (2022-2028)
-
8.7 South Korea Osteoarthritis Pain Drugs Consumption Forecast (2022-2028)
9 Global Osteoarthritis Pain Drugs Market Outlook by Types and Applications to 2022
-
9.1 Global Osteoarthritis Pain Drugs Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Oral Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Injection Consumption and Growth Rate (2017-2022)
-
9.1.3 Global External Consumption and Growth Rate (2017-2022)
-
9.2 Global Osteoarthritis Pain Drugs Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Medical Care Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Personal Care Consumption and Growth Rate (2017-2022)
10 Global Osteoarthritis Pain Drugs Market Outlook by Types and Applications to 2028
-
10.1 Global Osteoarthritis Pain Drugs Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Oral Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Injection Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global External Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Osteoarthritis Pain Drugs Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Medical Care Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Personal Care Consumption Forecast and Growth Rate (2022-2028)
11 Global Osteoarthritis Pain Drugs Import and Export Analysis (Top 5 Countries)
-
11.1 Global Osteoarthritis Pain Drugs Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Osteoarthritis Pain Drugs Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Osteoarthritis Pain Drugs Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Osteoarthritis Pain Drugs Market Competitive Analysis
-
14.1 Johnson & Johnson
-
14.1.1 Johnson & Johnson Company Details
-
14.1.2 Johnson & Johnson Osteoarthritis Pain Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Johnson & Johnson Osteoarthritis Pain Drugs Product and Service
-
14.2 Iroko Pharmaceuticals
-
14.2.1 Iroko Pharmaceuticals Company Details
-
14.2.2 Iroko Pharmaceuticals Osteoarthritis Pain Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Iroko Pharmaceuticals Osteoarthritis Pain Drugs Product and Service
-
14.3 Sanofi
-
14.3.1 Sanofi Company Details
-
14.3.2 Sanofi Osteoarthritis Pain Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Sanofi Osteoarthritis Pain Drugs Product and Service
-
14.4 Pfizer
-
14.4.1 Pfizer Company Details
-
14.4.2 Pfizer Osteoarthritis Pain Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Pfizer Osteoarthritis Pain Drugs Product and Service
-
14.5 Mylan
-
14.5.1 Mylan Company Details
-
14.5.2 Mylan Osteoarthritis Pain Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Mylan Osteoarthritis Pain Drugs Product and Service
-
14.6 GlaxoSmithKline
-
14.6.1 GlaxoSmithKline Company Details
-
14.6.2 GlaxoSmithKline Osteoarthritis Pain Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 GlaxoSmithKline Osteoarthritis Pain Drugs Product and Service
-
14.7 Almatica Pharma
-
14.7.1 Almatica Pharma Company Details
-
14.7.2 Almatica Pharma Osteoarthritis Pain Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Almatica Pharma Osteoarthritis Pain Drugs Product and Service
-
14.8 Lilly
-
14.8.1 Lilly Company Details
-
14.8.2 Lilly Osteoarthritis Pain Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Lilly Osteoarthritis Pain Drugs Product and Service
-
14.9 Bayer
-
14.9.1 Bayer Company Details
-
14.9.2 Bayer Osteoarthritis Pain Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Bayer Osteoarthritis Pain Drugs Product and Service
-
14.10 TEVA
-
14.10.1 TEVA Company Details
-
14.10.2 TEVA Osteoarthritis Pain Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 TEVA Osteoarthritis Pain Drugs Product and Service
-
14.11 Abbott Laboratories
-
14.11.1 Abbott Laboratories Company Details
-
14.11.2 Abbott Laboratories Osteoarthritis Pain Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 Abbott Laboratories Osteoarthritis Pain Drugs Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Osteoarthritis Pain Drugs
-
Figure Osteoarthritis Pain Drugs Picture
-
Table Global Osteoarthritis Pain Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Osteoarthritis Pain Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Osteoarthritis Pain Drugs Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Osteoarthritis Pain Drugs Consumption by Country (2017-2022)
-
Figure United States Osteoarthritis Pain Drugs Consumption and Growth Rate (2017-2022)
-
Table Europe Osteoarthritis Pain Drugs Consumption and Growth Rate (2017-2022)
-
Figure China Osteoarthritis Pain Drugs Consumption and Growth Rate (2017-2022)
-
Figure Japan Osteoarthritis Pain Drugs Consumption and Growth Rate (2017-2022)
-
Figure India Osteoarthritis Pain Drugs Consumption and Growth Rate (2017-2022)
-
Figure South Korea Osteoarthritis Pain Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Osteoarthritis Pain Drugs Consumption Forecast by Country (2022-2028)
-
Figure United States Osteoarthritis Pain Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Osteoarthritis Pain Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Osteoarthritis Pain Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Osteoarthritis Pain Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Osteoarthritis Pain Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Osteoarthritis Pain Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Oral Consumption and Growth Rate (2017-2022)
-
Figure Global Injection Consumption and Growth Rate (2017-2022)
-
Figure Global External Consumption and Growth Rate (2017-2022)
-
Figure Global Medical Care Consumption and Growth Rate (2017-2022)
-
Figure Global Personal Care Consumption and Growth Rate (2017-2022)
-
Figure Global Oral Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Injection Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global External Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Medical Care Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Personal Care Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Osteoarthritis Pain Drugs Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Osteoarthritis Pain Drugs Export by Region (Top 5 Countries) (2017-2028)
-
Table Johnson & Johnson (Foundation Year, Company Profile and etc.)
-
Table Johnson & Johnson Osteoarthritis Pain Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Johnson & Johnson Osteoarthritis Pain Drugs Product and Service
-
Table Iroko Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Iroko Pharmaceuticals Osteoarthritis Pain Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Iroko Pharmaceuticals Osteoarthritis Pain Drugs Product and Service
-
Table Sanofi (Foundation Year, Company Profile and etc.)
-
Table Sanofi Osteoarthritis Pain Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi Osteoarthritis Pain Drugs Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Osteoarthritis Pain Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Osteoarthritis Pain Drugs Product and Service
-
Table Mylan (Foundation Year, Company Profile and etc.)
-
Table Mylan Osteoarthritis Pain Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Mylan Osteoarthritis Pain Drugs Product and Service
-
Table GlaxoSmithKline (Foundation Year, Company Profile and etc.)
-
Table GlaxoSmithKline Osteoarthritis Pain Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline Osteoarthritis Pain Drugs Product and Service
-
Table Almatica Pharma (Foundation Year, Company Profile and etc.)
-
Table Almatica Pharma Osteoarthritis Pain Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Almatica Pharma Osteoarthritis Pain Drugs Product and Service
-
Table Lilly (Foundation Year, Company Profile and etc.)
-
Table Lilly Osteoarthritis Pain Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Lilly Osteoarthritis Pain Drugs Product and Service
-
Table Bayer (Foundation Year, Company Profile and etc.)
-
Table Bayer Osteoarthritis Pain Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bayer Osteoarthritis Pain Drugs Product and Service
-
Table TEVA (Foundation Year, Company Profile and etc.)
-
Table TEVA Osteoarthritis Pain Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table TEVA Osteoarthritis Pain Drugs Product and Service
-
Table Abbott Laboratories (Foundation Year, Company Profile and etc.)
-
Table Abbott Laboratories Osteoarthritis Pain Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Abbott Laboratories Osteoarthritis Pain Drugs Product and Service
-
